Samsung Galaxy S25 shows why Honor is eating its lunch in SA
Lindsey Schutters
More bullying? J&J will be investigated for high TB drug prices and abuse of patent laws
In an unprecedented move, South Africa's Competition Commission will investigate the American drugmaker Johnson & Johnson (J&J) for the high price it has been charging the country for the tuberculosis (TB) medicine bedaquiline, as well as for extending the tablets' 20-year patent until 2027 to block cheaper generics from entering the country.
Source: J&J.
South Africa has one of the highest TB disease rates in the world, and, despite it being curable, TB is the country’s top killer.
Bedaquiline is used to treat multidrug resistant (MDR) TB, a type of TB for which standard treatment doesn’t work. The drug, which is mostly used in combination with other medicines, has to be taken for six months and is considered a game changer because it has replaced treatment – up to two years of long, painful injections with serious side-effects such as hearing loss – with lower cure and higher death rates.
Read the full article by Mia Malan at Daily Maverick.
Related
WPP’s 2024 preliminary results see shares plunge 16% to a four year low 27 Feb 2025 Bankruptcy twist in J&J's attempt to settle cancer claims Katja Hamilton 19 Feb 2025 #MiningIndaba: Minerals Council says Trump funding freeze won’t affect mine HIV treatment Lindsey Schutters 5 Feb 2025 Study revolutionises global TB treatment 28 Aug 2024 New TB skin test could offer cheaper and easier way to detect the disease Yvette Naudé 5 Apr 2024 Next phase of TB vaccine clinical trial sparks hope of game-changing results – top SA scientist 28 Mar 2024 Researchers developing cellphone app that detects TB 25 Mar 2024 Artistry and innovation: The unlikely source of patents Patrick O'Brien and Dina Biagio 1 Feb 2024
Source: Daily Maverick
Daily Maverick is a unique blend of news, information, analysis and opinion delivered from our newsrooms in Cape Town and Johannesburg, South Africa. There are many ways to describe exactly what we do (and for the price of a cup of coffee we’re capable of talking your ears off about it), but the best way to understand the end result is to experience it. Every part of Daily Maverick is free-to-air and no payment is required, although free registration is required for a small subset of functions and pages.
Daily Maverick is run by an independently owned, private company with no affiliation to any other media group (or political party or religious organisation.) Follow Daily Maverick on Twitter at @dailymaverick.
Go to: https://www.dailymaverick.co.za/
